Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients

NCT03067350 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03067350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03067350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
January 31, 2019
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

haematological cancer patients, invasive aspergillosis, voriconazole